Casein kinase 2 regulates in vivo bone formation through its interaction with bone morphogenetic protein receptor type Ia

Bone

Volumn 49, Issue 5, 2011, Pages 944-954

  Bragdon, Beth ^a,b   Thinakaran, Shayamala ^a   Moseychuk, Oleksandra ^a   Gurski, Lauren ^a   Bonor, Jeremy ^a   Price, Christopher ^a   Wang, Liyun ^a   Beamer, Wesley G ^c   Nohe, Anja ^a  

^a UNIVERSITY OF DELAWARE   (United States)

^b UNIVERSITY OF MAINE   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

BMP type Ia receptor; BMP2; Bone; CK2; Smad

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; CASEIN KINASE II; MUTANT PROTEIN; PROTEIN NFATC1; REGULATOR PROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE AREA; BONE DENSITY; BONE GROWTH; BONE MINERALIZATION; BONE STRUCTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; IN VIVO STUDY; MICROSCOPY; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; POINT MUTATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ABSORPTIOMETRY, PHOTON; ANIMALS; BONE DENSITY; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; CASEIN KINASE II; CELL LINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NFATC TRANSCRIPTION FACTORS; OSTEOGENESIS; POINT MUTATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 80054841445     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.06.037     Document Type: Article

References (37)

1. Victoria G., Petrisor B., Drew B., Dick D. Bone stimulation for fracture healing: what's all the fuss?. Indian J Orthop 2009, 43:117-120.
2. Bishop G.B., Einhorn T.A. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 2007, 31:721-727.
3. Musculoskeletal injuries report: incidence, risk factors and prevention 2000, American Academy of Orthopaedic Surgeons.
4. National Trauma Data Bank Report 2002, The American College of Surgeons.
5. Sfeir C., Ho L., Doll B.A., Azari K., Hollinger J.O. Fracture Repair. Bone Regeneration and Repair Biology and Clinical Applications 2005, 21-44. Humana Press, Totowa. J.R. Lieberman, G.E. Friedlaender (Eds.).
6. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., Einhorn T., Tabin C.J., Rosen V. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006, 38:1424-1429.
7. Noth U., Tuli R., Seghatoleslami R., Howard M., Shah A., Hall D.J., Hickok N.J., Tuan R.S. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 2003, 291:201-211.
8. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Choi J.Y., Ryoo H.M., Bae S.C. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000, 20:8783-8792.
9. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., Sung J.H., Wozney J.M., Ryoo H.M. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 2003, 278:34387-34394.
10. Afzal F., Pratap J., Ito K., Ito Y., Stein J.L., van Wijnen A.J., Stein G.S., Lian J.B., Javed A. Smad function and intranuclear targeting share a Runx2 motif required for osteogenic lineage induction and BMP2 responsive transcription. J Cell Physiol 2005, 204:63-72.
11. Korchynskyi O., ten Dijke P. Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J Biol Chem 2002, 277:4883-4891.
12. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
13. Liu T., Gao Y., Sakamoto K., Minamizato T., Furukawa K., Tsukazaki T., Shibata Y., Bessho K., Komori T., Yamaguchi A. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J Cell Physiol 2007, 211:728-735.
14. Bragdon B., Thinakaran S., Moseychuk O., King D., Young K., Litchfield D.W., Petersen N.O., Nohe A. Casein kinase 2 beta-subunit is a regulator of bone morphogenetic protein 2 signaling. Biophys J 2010, 99:897-904.
15. Veis A., Sfeir C., Wu C.B. Phosphorylation of the proteins of the extracellular matrix of mineralized tissues by casein kinase-like activity. Crit Rev Oral Biol Med 1997, 8:360-379.
16. Litchfield D.W. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 2003, 369:1-15.
17. Vilk G., Weber J.E., Turowec J.P., Duncan J.S., Wu C., Derksen D.R., Zien P., Sarno S., Donella-Deana A., Lajoie G., Pinna L.A., Li S.S., Litchfield D.W. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells. Cell Signal 2008, 20:1942-1951.
18. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 1999, 286:1946-1949.
19. Gilboa L., Nohe A., Geissendorfer T., Sebald W., Henis Y.I., Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 2000, 11:1023-1035.
20. Pohl F., Hassel S., Nohe A., Flentje M., Knaus P., Sebald W., Koelbl O. Radiation-induced suppression of the Bmp2 signal transduction pathway in the pluripotent mesenchymal cell line C2C12: an in vitro model for prevention of heterotopic ossification by radiotherapy. Radiat Res 2003, 159:345-350.
21. Yanagisawa M., Suzuki N., Mitsui N., Koyama Y., Otsuka K., Shimizu N. Effects of compressive force on the differentiation of pluripotent mesenchymal cells. Life Sci 2007, 81:405-412.
22. Bragdon B., Thinakaran S., Bonor J., Underhill T.M., Petersen N.O., Nohe A. FRET reveals novel protein-receptor interaction of bone morphogenetic proteins receptors and adaptor protein 2 at the cell surface. Biophys J 2009, 97:1428-1435.
23. Funasako M., Taniji M., Fujimoto K., Higaskimoto Y., Uetani K., Suruda T., Sato H., Nakai S., Fujimoto H., Ohata M. Areal bone mineral density and bone phosphatase activites in experimental diabetes mellitus. J Bone Miner Metab 1996, 14:153-157.
24. Deng F., Ling J., Ma J., Liu C., Zhang W. Stimulation of intramembranous bone repair in rats by ghrelin. Exp Physiol 2008, 93:872-879.
25. Alam I., Carr L.G., Liang T., Liu Y., Edenberg H.J., Econs M.J., Turner C.H. Identification of genes influencing skeletal phenotypes in congenic P/NP rats. J Bone Miner Res 2010, 25:1314-1325.
26. Wiren K.M., Semirale A.A., Zhang X.W., Woo A., Tommasini S.M., Price C., Schaffler M.B., Jepsen K.J. Targeting of androgen receptor in bone reveals a lack of androgen anabolic action and inhibition of osteogenesis: a model for compartment-specific androgen action in the skeleton. Bone 2008, 43:440-451.
27. Kasukawa Y., Baylink D.J., Wergedal J.E., Amaar Y., Srivastava A.K., Guo R., Mohan S. Lack of insulin-like growth factor I exaggerates the effect of calcium deficiency on bone accretion in mice. Endocrinology 2003, 144:4682-4689.
28. Calvi L.M., Sims N.A., Hunzelman J.L., Knight M.C., Giovannetti A., Saxton J.M., Kronenberg H.M., Baron R., Schipani E. Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone. J Clin Invest 2001, 107:277-286.
29. Sheng M.H., Lau K.H., Beamer W.G., Baylink D.J., Wergedal J.E. In vivo and in vitro evidence that the high osteoblastic activity in C3H/HeJ mice compared to C57BL/6J mice is intrinsic to bone cells. Bone 2004, 35:711-719.
30. Rawadi G., Vayssiere B., Dunn F., Baron R., Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 2003, 18:1842-1853.
31. Hill T.P., Spater D., Taketo M.M., Birchmeier W., Hartmann C. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev Cell 2005, 8:727-738.
32. Zhang M., Yan Y., Lim Y.B., Tang D., Xie R., Chen A., Tai P., Harris S.E., Xing L., Qin Y.X., Chen D. BMP-2 modulates beta-catenin signaling through stimulation of Lrp5 expression and inhibition of beta-TrCP expression in osteoblasts. J Cell Biochem 2009, 108:896-905.
33. Komarova S.V., Pereverzev A., Shum J.W., Sims S.M., Dixon S.J. Convergent signaling by acidosis and receptor activator of NF-kappaB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc Natl Acad Sci USA 2005, 102:2643-2648.
34. Sotillo Rodriguez J.E., Mansky K.C., Jensen E.D., Carlson A.E., Schwarz T., Pham L., MacKenzie B., Prasad H., Rohrer M.D., Petryk A., Gopalakrishnan R. Enhanced osteoclastogenesis causes osteopenia in twisted gastrulation-deficient mice through increased BMP signaling. J Bone Miner Res 2009, 24:1917-1926.
35. Kaneko H., Arakawa T., Mano H., Kaneda T., Ogasawara A., Nakagawa M., Toyama Y., Yabe Y., Kumegawa M., Hakeda Y. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 2000, 27:479-486.
36. Blackwell K.A., Hortschansky P., Sanovic S., Choudhary S., Raisz L.G., Pilbeam C.C. Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. Prostaglandins Other Lipid Mediat 2009, 90:76-80.
37. Wutzl A., Rauner M., Seemann R., Millesi W., Krepler P., Pietschmann P., Ewers R. Bone morphogenetic proteins 2, 5, and 6 in combination stimulate osteoblasts but not osteoclasts in vitro. J Orthop Res 2010, 28:1431-1439.